ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,994Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 749

$643K Total Retail Price of All Prescriptions

Rank: 86 out of 749

361 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 361 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

50% of this provider’s 361 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

4% of this provider’s 7,578 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 822 398 S3 1 12
FUROSEMIDE 636 410 2 2
METOPROLOL TARTRATE 456 334 3 7
ACETAMINOPHEN-CODEINE 441 298 S3 4 79
DIOVAN 358 256 5 14
CARISOPRODOL 350 102 R 6 154
SIMVASTATIN 325 223 7 5
AMLODIPINE BESYLATE 293 191 8 1
CLONIDINE HCL 291 205 9 15
CRESTOR 267 200 10 43
LISINOPRIL 251 138 11 4
CARVEDILOL 219 175 12 11
OMEPRAZOLE 207 134 13 6
NIFEDIPINE ER 205 165 14 21
POTASSIUM CHLORIDE 200 168 15 37
LOSARTAN POTASSIUM 192 120 16 9
METFORMIN HCL 180 115 17 22
ATORVASTATIN CALCIUM 178 100 18 18
TRAMADOL HCL 177 135 19 47
GLYBURIDE 162 99 R 20 103
LEVOTHYROXINE SODIUM 141 123 21 13
TAMSULOSIN HCL 135 99 22 29
ZOLPIDEM TARTRATE 127 56 23 24
PROAIR HFA 124 94 24 98
AZITHROMYCIN 109 71 25 65
IBUPROFEN 107 55 26 118
VENTOLIN HFA 107 57 26 225
GLIPIZIDE 102 44 28 32
LEVOFLOXACIN 99 68 29 81
DONEPEZIL HCL 98 97 30 55
RENVELA 96 19 31 3
KLOR-CON 8 95 57 32 159
DIOVAN HCT 94 76 33 68
GABAPENTIN 94 71 33 25
PHENYTOIN SODIUM EXTENDED 93 37 35 248
PANTOPRAZOLE SODIUM 93 61 35 30
CLOPIDOGREL 89 74 37 42
LIPITOR 81 55 38 71
LYRICA 77 44 39 111
ENALAPRIL MALEATE 76 72 40 62
AVODART 74 59 41 73
OXYCODONE HCL 69 53 S2 42 267
DILAUDID 66 19 S2 10 43 361
ATENOLOL 62 49 44 20
HYDRALAZINE HCL 61 34 45 19
TERAZOSIN HCL 60 46 46 58
AMITRIPTYLINE HCL 59 13 R 47 168
LACTULOSE 57 49 48 120
NEXIUM 53 34 49 34
ALLOPURINOL 53 51 49 10
DEXILANT 52 20 51 75
MEGESTROL ACETATE 51 30 R 52 69
BENAZEPRIL HCL 50 33 53 23
ADVAIR DISKUS 50 30 53 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.